Breast Cancer Research and Treatment
(BREAST CANCER RES TR) 《乳腺癌研究与治疗》

REVIEW

Assessment accuracy of core needle biopsy for hormone receptors in breast cancer: a meta-analysis

Shichao Li, Xinhua Yang, Yi Zhang, Linjun Fan and Fan Zhang, et al.

• Show Summary
• Download PDF (728.0 KB)
• View HTML

335-346

REVIEW

Mortality, leukemic risk, and cardiovascular toxicity of adjuvant anthracycline and taxane chemotherapy in breast cancer: a meta-analysis

Fausto Petrelli, Karen Borgonovo, Mary Cabiddu, Veronica Lonati and Sandro Barni

• Show Summary
• Download PDF (480.4 KB)
• View HTML
• Supplemental

347-354

REVIEW

Risk of rash with the anti-HER2 dimerization antibody pertuzumab: a meta-analysis

Aaron M. Drucker, Shenhong Wu, Chau T. Dang and Mario E. Lacouture

• Show Summary
• Download PDF (295.4 KB)
• View HTML

355-366

REVIEW

Systemic therapy options in BRCA mutation-associated breast cancer

Soley Bayraktar and Stefan Glück

• Show Summary
• Download PDF (353.7 KB)
• View HTML

367-380

REVIEW

Physical activity and mammographic breast density: a systematic review

Lusine Yaghjyan, Graham A. Colditz and Kathleen Wolin

• Show Summary
• Download PDF (1.5 MB)
• View HTML
• Supplemental

381-390

PRECLINICAL STUDY

The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer

Kristin Jonsdottir, Hui Zhang, Darshni Jhagroe, Ivar Skaland and Aida Slewa, et al.

• Show Summary
• Download PDF (771.8 KB)
• View HTML

391-401

PRECLINICAL STUDY

Beyond radiation therapy: photodynamic therapy maintains structural integrity of irradiated healthy and metastatically involved vertebrae in a pre-clinical in vivo model

Victor C. K. Lo, Margarete K. Akens, Sara Moore, Albert J. M. Yee and Brian C. Wilson, et al.

• Show Summary
• Download PDF (1.1 MB)
• View HTML
• Supplemental

403-413

PRECLINICAL STUDY

Loss of Dicer expression is associated with breast cancer progression and recurrence

Sarkawt M. Khoshnaw, Emad A. Rakha, Tarek M. Abdel-Fatah, Christopher C. Nolan and Zsolt Hodi, et al.

• Show Summary
• Download PDF (1,014.0 KB)
• View HTML

415-432

PRECLINICAL STUDY

Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures

Peter Kabos, Jessica Finlay-Schultz, Chunling Li, Enos Kline and Christina Finlayson, et al.

• Show Summary
• Download PDF (1.9 MB)
• View HTML
• Supplemental

433-444

PRECLINICAL STUDY

Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells

Warren Fiskus, Stacey L. Hembruff, Rekha Rao, Priyanka Sharma and Ramesh Balusu, et al.

• Show Summary
• Download PDF (1.6 MB)
• View HTML
• Supplemental

445-458

PRECLINICAL STUDY

Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion

Tao Zhang, Jingjie Li, Yanmin Dong, Dong Zhai and Li Lai, et al.

• Show Summary
• Download PDF (1.2 MB)
• View HTML
• Supplemental

459-467

PRECLINICAL STUDY

Peritumoral FOXP3⁺ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3⁺regulatory T cell is prognostic predictor of breast cancer patients

Fangfang Liu, Yaqing Li, Meijing Ren, Xinmin Zhang and Xiaojing Guo, et al.

• Show Summary
• Download PDF (348.0 KB)
• View HTML

469-479

PRECLINICAL STUDY

Serum and glucocorticoid-regulated kinase 1 (SGK1) activation in breast cancer: requirement for mTORC1 activity associates with ER-alpha expression

Ben A. Hall, Tae Yeon Kim, Maxwell N. Skor and Suzanne D. Conzen

• Show Summary
• Download PDF (765.6 KB)
• View HTML
• Supplemental

481-493

PRECLINICAL STUDY

Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer

Johanna Tuomela, Jouko Sandholm, Peeter Karihtala, Joanna Ilvesaro and Katri S. Vuopala, et al.

• Show Summary
• Download PDF (771.7 KB)
• View HTML
• Supplemental

495-503

PRECLINICAL STUDY

Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor

Fathima R. Kona, Karri Stark, Luke Bisoski, Daniela Buac and Qiuzhi Cui, et al.

• Show Summary
• Download PDF (952.6 KB)
• View HTML

505-517

PRECLINICAL STUDY

Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib

Anneleen Daemen, Denise M. Wolf, James E. Korkola, Obi L. Griffith and Jessica R. Frankum, et al.

• Show Summary
• Download PDF (537.7 KB)
• View HTML
• Supplemental

519-530

PRECLINICAL STUDY

MMP-9 increases HER2/neu expression and alters apoptosis levels in human mammary epithelial cells (HMEC)

Matilda Fatunmbi, Justin Shelton and Susan M. Aronica

• Show Summary
• Download PDF (417.8 KB)
• View HTML

531-537

CLINICAL TRIAL

TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy

Jiayu Wang, Binghe Xu, Peng Yuan, Pin Zhang and Qing Li, et al.

• Show Summary
• Download PDF (241.6 KB)
• View HTML

539-548

CLINICAL TRIAL

Characterisation of tumour-infiltrating macrophages: impact on response and survival in patients receiving primary chemotherapy for breast cancer

Steven D. Heys, Keith N. Stewart, Emma J. McKenzie, Iain D. Miller and Simon Y. C. Wong, et al.

• Show Summary
• Download PDF (325.4 KB)
• View HTML

549-553

CLINICAL TRIAL

Regular screening mammography before the diagnosis of breast cancer reduces black:white breast cancer differences and modifies negative biological prognostic factors

Paula Grabler, Danielle Dupuy, Jennifer Rai, Sean Bernstein and David Ansell

• Show Summary
• Download PDF (166.4 KB)
• View HTML

555-569

EPIDEMIOLOGY

Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women

A. J. Agboola, A. A. Musa, N. Wanangwa, T. Abdel-Fatah and C. C. Nolan, et al.

• Show Summary
• Download PDF (744.7 KB)
• View HTML

571-580

EPIDEMIOLOGY

Mammographic density and breast cancer risk in White and African American Women

Hilda Razzaghi, Melissa A. Troester, Gretchen L. Gierach, Andrew F. Olshan and Bonnie C. Yankaskas, et al.

• Show Summary
• Download PDF (217.3 KB)
• View HTML
• Supplemental

581-589

EPIDEMIOLOGY

Preventing weight gain during adjuvant chemotherapy for breast cancer: a dietary intervention study

A. Villarini, P. Pasanisi, M. Raimondi, G. Gargano and E. Bruno, et al.

• Show Summary
• Download PDF (233.3 KB)
• View HTML

591-602

EPIDEMIOLOGY

Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system

Marilyn L. Kwan, Ling Shen, Julie R. Munneke, Emily K. Tam and Paula N. Partee, et al.

• Show Summary
• Download PDF (227.3 KB)
• View HTML

603-609

EPIDEMIOLOGY

Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case–control study

Isabelle Le Ray, Sophie Dell’Aniello, Franck Bonnetain, Laurent Azoulay and Samy Suissa

• Show Summary
• Download PDF (182.3 KB)
• View HTML

611-618

EPIDEMIOLOGY

Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women’s Health Initiative observational study

Christopher I. Li, Justin E. Mirus, Yuzheng Zhang, Arturo B. Ramirez and Jon J. Ladd, et al.

• Show Summary
• Download PDF (217.6 KB)
• View HTML

619-627

BRIEF REPORT

Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer

Y. Delpech, Y. Wu, K. R. Hess, L. Hsu and M. Ayers, et al.

• Show Summary
• Download PDF (357.1 KB)
• View HTML
• Supplemental